In January 2025 my mom’s lung cancer spread to her brain. The drug with the best chance of helping her was approved in China but not here.
A doctor told me, almost as an aside, that if she were Chinese she could buy it at a pharmacy.
So I flew to Shanghai and came home with 26 boxes in my luggage. That was 19 months ago. My mom is still here, still working, and in her words has had an amazing three years.
The drug was approved in China in 2023. The FDA approved it in July 2025. It still is not for sale here. I know of at least 30 Americans who have made the same trip.
I have been scared to tell this story because I worried it could cost my mom access to the medicine keeping her alive. But the problem matters more than my silence. These drugs need to be developed and available here, and that means FDA reform.
Art Allen at KFF Health News told our story this week. It also ran in The Washington Post.
https://t.co/tHKV3L004L
Markets are like a game - momentum is real. But can flip on a dime. There are always reason to de-risk or exit markets but then the beauty of compounding returns doesn't work. Ride the wave, markets always find a way to stay bullish over longer time horizons. I do not expect this dip to last long esp in an election year
The Bears have two good, young tackles, two good,young corners, Sweat as an edge — need one more — and get a perceived franchise QB with the first pick. Plus have a big-time WR in Moore and now have Allen to go with TE Kmet. They get it. Watch out. Send a bottle to the Panthers.
Attention to details matter. Chiefs confirming they would’ve gone for 2 if Niners scored a Touchdown all but seals the decision to receive as one of the dumbest Super Bowl Coaching decisions ever. No one should be defending it even though a ton of people tried